HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $842 | +5.2% | 9,395 | 0.0% | 0.01% | +25.0% |
Q2 2023 | $800 | +3.0% | 9,395 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $777 | +5.1% | 9,395 | 0.0% | 0.00% | -20.0% |
Q4 2022 | $739 | -99.9% | 9,395 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $696,000 | +13.7% | 9,395 | 0.0% | 0.01% | +25.0% |
Q2 2022 | $612,000 | +3.0% | 9,395 | 0.0% | 0.00% | +33.3% |
Q1 2022 | $594,000 | +19.3% | 9,395 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $498,000 | -24.9% | 9,395 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $663,000 | +5.9% | 9,395 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $626,000 | -36.6% | 9,395 | +5.6% | 0.00% | -50.0% |
Q1 2021 | $987,000 | -6.5% | 8,895 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $1,056,000 | +36.1% | 8,895 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $776,000 | -51.3% | 8,895 | -50.0% | 0.01% | -14.3% |
Q2 2020 | $1,594,000 | – | 17,790 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |